Teprotumumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Teprotumumab

Published:2021-11 Issue:11 Volume:128 Page:1627-1651
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Winn Bryan J.,Kersten Robert C.

Funder

Research to Prevent Blindness

National Institutes of Health

Columbia University

U.S. Food and Drug Administration

National Eye Institute

Publisher

Elsevier BV

Subject

Ophthalmology

Reference168 articles.

1. Epidemiologic aspects of Hashimoto’s thyroiditis and Graves’ disease in Rochester, Minnesota (1935–1967), with special reference to temporal trends;Furszyfer;Metabolism,1972

2. The spectrum of thyroid disease in a community: the Whickham survey;Tunbridge;Clin Endocrinol (Oxf),1977

3. Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease;Lazarus;Best Pract Res Clin Endocrinol Metab,2012

4. The incidence of Graves’ ophthalmopathy in Olmsted County, Minnesota;Bartley;Am J Ophthalmol,1995

5. Clinical features of Graves’ ophthalmopathy in an incidence cohort;Bartley;Am J Ophthalmol,1996

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Teprotumumab-associated aural fullness and ageusia: A case report of persistent complications following thyroid eye disease treatment;AJO International;2024-10

2. Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system;Frontiers in Pharmacology;2024-08-09

3. Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment;The Journal of Clinical Endocrinology & Metabolism;2024-06-15

4. Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion;American Journal of Ophthalmology Case Reports;2024-06

5. PAPP-A as a Potential Target in Thyroid Eye Disease;The Journal of Clinical Endocrinology & Metabolism;2024-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3